Selected discussion
Effects of a resveratrol-containing nutraceutical on cardiac biomarkers, echocardiographic parameters, and oxidative stress in dogs with naturally occurring cardiac disease.
Clinical evidence update from Frontiers in veterinary science
Clinical Context
Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated
A study published in Frontiers in veterinary science in 2026 evaluated effects of a resveratrol-containing nutraceutical on cardiac biomarkers, echocardiographic parameters, and oxidative stress in dogs with naturally occurring cardiac disease..
Key Findings
Cardiac diseases such as myxomatous mitral valve disease (MMVD) and dilated cardiomyopathy (DCM) are common in dogs and are associated with progressive cardiac dysfunction and increased oxidative stress. Despite the widespread use of nutraceuticals in veterinary medicine, clinical evidence supporting their efficacy remains limited. This study aimed to evaluate the eff…
Discussion thread
Community replies
Follow the line down to read the conversation in order.
No replies yet
No replies yet. Be the first professional to join this discussion.
Use the reply box above to start the conversation.
October 10, 2026 · Evidence feed live

Join this discussion
Add your reply
Share a professional insight, ask a focused question, or add relevant clinical experience.
Member participation
Log in to join the discussion
Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.